Cabaletta Bio, Inc. (CABA)

NASDAQ: CABA · Real-Time Price · USD

3.130

-0.060 (-1.88%)

At close: Aug 21, 2026, 4:00 PM EDT

3.180

+0.050 (1.60%)

After-hours: Aug 21, 2026, 7:30 PM EDT

Cabaletta Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	225.1	82.98	163.96	193.24	81.61	122.22
Short-Term Investments	-	50.62	-	48.01	24.94	-
Cash & Short-Term Investments	225.1	133.6	163.96	241.25	106.55	122.22
Cash Growth	15.63%	-18.52%	-32.04%	126.43%	-12.83%	12.48%
Prepaid Expenses	5.93	5.27	2.71	3.24	2.29	2.32
Total Current Assets	231.03	138.87	166.68	244.49	108.83	124.54
Property, Plant & Equipment	19.49	21.05	16.08	7.45	7.57	1.44
Other Long-Term Assets	6.21	5.16	2.29	1.71	0.57	0.36
Total Assets	256.73	165.08	185.05	253.65	116.97	126.34

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.81	6.64	4.92	4.55	2.46	2.33
Accrued Expenses	14.55	19.22	12.15	7.85	4.81	5.99
Current Portion of Leases	19.49	24.22	9.98	3.56	2.18	-
Other Current Liabilities	0.06	0.08	0.04	0.04	0.04	0.05
Total Current Liabilities	39.91	50.15	27.09	15.99	9.49	8.38
Long-Term Leases	6.23	2.88	5.63	1.46	2.96	-
Total Liabilities	46.14	53.03	32.71	17.45	12.45	8.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	-	-	-
Additional Paid-In Capital	822.08	628.98	501.44	469.4	270.13	230.54
Retained Earnings	-611.49	-516.96	-349.1	-233.24	-165.56	-112.59
Comprehensive Income & Other	-	0.03	-	0.04	-0.05	-
Total Common Equity	210.59	112.05	152.34	236.2	104.52	117.96
Shareholders' Equity	210.59	112.05	152.34	236.2	104.52	117.96
Total Liabilities & Equity	256.73	165.08	185.05	253.65	116.97	126.34

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	25.71	27.1	15.6	5.02	5.14	-
Net Cash (Debt)	199.39	106.5	148.36	236.23	101.41	122.22
Net Cash Growth	17.43%	-28.21%	-37.20%	132.95%	-17.03%	12.48%
Net Cash Per Share	1.70	1.33	3.00	5.77	3.46	4.75
Filing Date Shares Outstanding	169.55	111.32	50.74	48.24	31.34	28.98
Total Common Shares Outstanding	167.73	100.48	50.74	47.82	29.45	28.93
Working Capital	191.12	88.72	139.59	228.5	99.35	116.16
Book Value Per Share	1.26	1.12	3.00	4.94	3.55	4.08
Tangible Book Value	210.59	112.05	152.34	236.2	104.52	117.96
Tangible Book Value Per Share	1.26	1.12	3.00	4.94	3.55	4.08
Machinery	-	8.96	8.14	6.22	4.83	2.57
Leasehold Improvements	-	0.11	0.11	0.11	0.11	0.06

SEC Filings: 10-K · 10-Q